Mounjaro mimics the effects of not one but two hormones (GLP-1 and GIP) to help regulate insulin production, blood sugar control, and satiety
The diagnosis is oral melanoacanthoma
A patient on "the best" GLP-1 medication (by name) who titrates too quickly, skips doses, or stops at the first side effect will have worse outcomes than a patient on "the worst" GLP-1 medication who titrates slowly, stays consistent, and reaches maintenance dose
This medication promotes significant weight loss, improved blood sugar control, and overall health
The GLP-1 agonist Semaglutide GLP-1 increases insulin release, lowers glucagon release, delays gastric emptying, and reduces appetite
In some studies , its shown modest weight loss benefits, probably because of its effects on blood sugar and [support of] fat metabolism, which is the breakdown, storage, and usage of fats